EVA is an important if uncommon disease of horses. Potential economic losses attributable to EVA include direct losses from abortion, pneumonia in neonates, and febrile disease in performance horses. Indirect losses are those associated with national and international trade/animal movement regulations, particularly those pertaining to persistently infected carrier stallions and their semen. However, EAV infection and EVA are readily prevented through serological and virological screening of horses, coupled with sound management practices that include appropriate quarantine and strategic vaccination.
CITATION STYLE
MacLachlan, N. J., & Balasuriya, U. B. (2006). Equine viral arteritis. In Advances in Experimental Medicine and Biology (Vol. 581, pp. 429–433). Springer New York. https://doi.org/10.1007/978-0-387-33012-9_77
Mendeley helps you to discover research relevant for your work.